Shockwave Therapy as First-Line Treatment for Peyronie's Disease: A Prospective Study

Skolarikos, Andreas; Alargof, E.; Rigas, Andreas S.; Deliveliotis, Ch.; Konstantinidis, Evdokimos I.

doi:10.1089/end.2005.19.11

Cited by 30 publications

(13 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Most of these ED patients had an organic etiology, such as a vascular lesion [7,8], a nerve injury [9], or a lesion of the cavernous body of E U R O P E A N U R O L O G Y X X X ( 2 0 1 6 ) X X X -X X X [10][11][12][13]. One study focused on ED patients with chronic pelvic pain [14].…”

Section: Evidence Synthesismentioning

confidence: 99%

Low-intensity Extracorporeal Shock Wave Treatment Improves Erectile Function: A Systematic Review and Meta-analysis

et al. 2017

View full text Add to dashboard Cite

Section: Evidence Synthesismentioning

confidence: 99%

Low-intensity Extracorporeal Shock Wave Treatment Improves Erectile Function: A Systematic Review and Meta-analysis

et al. 2017

View full text Add to dashboard Cite

“…Although a large-scale randomized clinical trial comparing treatments for Peyronie's disease is not yet available, several studies have reported that extracorporeal shock wave therapy (ESWT) is a useful alternative to relieve painful erections [5][6][7][8][9][10][11][12][13][14][15]. Almost all the abovementioned studies considered that ESWT is a non-invasive modality and appears to be a safe and effective procedure.…”

Section: Introductionmentioning

confidence: 99%

Extracorporeal shockwave therapy for Peyronie's disease: an alternative treatment?

Poulakis¹,

Skriapas²,

Vries³

et al. 2006

Asian J Andrology

View full text Add to dashboard Cite

Cite this abstract as: Wang X. Clinical observation on systematic desensitization therapy for 35 cases of simple premature ejaculation. Transl Androl Urol 2017;6(Suppl 3): AB014. Abstract: Extracorporeal shock wave (ESW) was introduced in urology for treatment of Peyronie's disease (PD) near 20 years. The treatment is not invasive and appears to be effective. However, evidences on long-term follow-up of ESW in PD are still lacking. In addition, effects of ESW on PD are inconsistent. Some studies believed that ESW may resolve pain in PD patients, but not reduce curvature and plaques size. Note that our current evidences supported that ESW could both relieve pain and reduce the size of plaques. Two explanations of the mechanism of how ESW relieve pain looks plausible; one is that direct damage to the plaque and the other is that ESW causes increasing vascularity of the area by some unknown mechanism. The aim of this report was to summarize contemporary evidences regarding the clinical efficacy of ESW as a conservative treatment, and to report our recent data. Abstract: This paper reviews the literatures published in the professional journals in the past 20 years, Inductive summarizing the etiology, pathogenesis and syndrome differentiation and typing of chronic prostatitis, prostatic hyperplasia, urinary calculi and erectile dysfunction in TCM, exploring the application of Chinese medicine, such as internal treatment, external treatment and acupuncture, in the treatment of urological Andrology, expounding the research progress of Chinese medicine technology, affirming the multiple advantages of the traditional Chinese medicine technology in the prevention and treatment of urinary Andrology disease, and prospecting the development of Chinese medicine technology in the future.

show abstract

“…Although penile extracorporeal shock wave therapy (ESWT) has been proposed as a nonsurgical PD treatment and a few reports demonstrated a beneficial effect [57,58], most studies did not observe any significant change in penile curvature [ …”

Section: Extracorporeal Shock Wave Therapymentioning

confidence: 99%

Treatment of Peyronie’s Disease: 2012 Update

Şerefoğlu

2011

Curr Urol Rep

View full text Add to dashboard Cite

Peyronie's disease (PD) is the occurrence of a fibrous inelastic scar of the tunica albuginea of the penis. It is a relatively common disorder among men, with a reported prevalence of 3% to 8%. It is often associated with penile pain, anatomical deformities in the erect state, and difficulty with intromission. Because the exact pathophysiology of PD remains unknown and standards for evaluating or reporting treatment outcomes are unclear, research on effective therapies has been limited. The benefits of nonsurgical treatment options are conflicting and further controlled studies are required before any therapy can be fully recommended. The success of surgery has been well documented; however, surgery is invasive and costly and carries potential side effects. Patients who report stable disease that has been present for longer than 12 months and who experience penile deformity preventing satisfactory sexual intercourse are best suited for surgery. Additionally, failed conservative management and a patient's preference for definitive correction are important additional indications for surgical treatment.

show abstract

Shockwave Therapy as First-Line Treatment for Peyronie's Disease: A Prospective Study

Abstract: Our results support SWT as an effective and safe first-line treatment for Peyronie's disease.

Cited by 30 publications

References 15 publications

Low-intensity Extracorporeal Shock Wave Treatment Improves Erectile Function: A Systematic Review and Meta-analysis

Low-intensity Extracorporeal Shock Wave Treatment Improves Erectile Function: A Systematic Review and Meta-analysis

Extracorporeal shockwave therapy for Peyronie's disease: an alternative treatment?

Treatment of Peyronie’s Disease: 2012 Update

Contact Info

Product

Resources

About